Support The Moscow Times!

Now is the time to support independent reporting from Russia!

Contribute Today

Pharmstandard Sales Up 84%

Drug maker Pharmstandard said Thursday its third-quarter sales soared 84 percent, year-on-year, boosted by an early state tender for anti-cancer drugs.

Sales totaled 14.7 billion rubles, versus 8 billion rubles in the same period last year, the company said in a statement.

It said sales of Johnson & Johnson's anti-cancer drug Velcade totaled 4.8 billion rubles, accounting for one-third of total revenue, after the government shifted its tender to the third quarter from the fourth quarter.

As a result, total sales of third-party products soared 308 percent to stand at 8.1 billion rubles, while sales of the company's own drugs were up 8.3 percent to 6.2 billion rubles.


Related articles:

Read more

Russia media is under attack.

At least 10 independent media outlets have been blocked or closed down over their coverage of the war in Ukraine.

The Moscow Times needs your help more than ever as we cover this devastating invasion and its sweeping impacts on Russian society.